Moreover, it has been postulated that CHIP might influence cancer progression and recurrence, possibly due to cell–cell interactions between CHIP clones and cancer cells [41], impacting the immune function on immune surveillance and promoting an increased inflammatory milieu due to the clonal expansion of effector cells, or reduced tolerance toward cancer-directed therapy [42,43]. The gene discussed is STUB1; the disease is cancer.